Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AEHR vs GSK✓SelectedUSD · GSKAEHR vs GSK performance historyLatest closeAs of-6.65%11/13
Stock and ETF performance explorer

AEHR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+143.5%
GSK return
+65.8%
Excess return
+77.7%
Maximum drawdown
-77.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.7%+0.5%-7.2%-6.7%
7D+6.4%+1.1%+5.2%+6.3%
30D-20.3%+6.3%-26.6%-20.5%
3M-53.8%+1.8%-55.6%-53.8%
6M-44.8%+1.7%-46.5%-45.2%
YTD+182.2%+6.5%+175.7%+176.9%
1Y+174.7%+9.5%+165.2%+167.7%
3Y+143.5%+65.3%+78.2%+125.6%
All+143.5%+65.8%+77.7%+125.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling